Integrin αvβ8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-β1.

导出 OA

翻译打印收藏纠错

作者： Mingliang,Zhou ^[1] ; Jun,Niu ^[2] ; Jinshen,Wang ^[3] ; Huijie,Gao ^[1] ; Muhammad,Shahbaz ^[2] ; Zhengchuan,Niu ^[3] ; Zequn,Li ^[3] ; Xueqing,Zou ^[4] ; Benjia,Liang ^[5]

作者单位： Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China. ^[1] Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China. ^[2] Department of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan 250012 Shandong, China. ^[3] Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 20032, China. ^[4] Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China. ^[5]

关键词 TGF-β1 cell invasiveness colon cancer integrin αvβ8 prognostic factors

DOI 10.7150/jca.43826

PMID 32328185

发布时间 2023-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交